A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.
Key Inclusion Criteria
Key Exclusion Criteria
Buenos Aires, Buenos Aires 1431, Argentina
Capital Federal, Buenos Aires 1034, Argentina
Capital Federal, Buenos Aires 1429, Argentina
Capital Federal, Buenos Aires C1056ABJ, Argentina
Capital Federal, Buenos Aires C1425AGC, Argentina
Ciudad Auton., Buenos Aires C1505CWB, Argentina
Ciudad Auton, Buenos Aires C1408INH, Argentina
Df, Mexico City 11800, Mexico
Guadalajara, Mexico City 44670, Mexico
Zapopan, Mexico City 45150, Mexico
Monterrrey, Nuevo León 64700, Mexico